Literature DB >> 16901766

Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease.

Manal F Abdelmalek1, Chen Liu, Jonathan Shuster, David R Nelson, Nabih R Asal.   

Abstract

BACKGROUND & AIMS: An association between nonalcoholic fatty liver disease (NAFLD) and the insulin resistance (IR) syndrome exists. Familial clustering of IR may support a genetic predisposition to NAFLD or cryptogenic cirrhosis (CC).
METHODS: Patients with NAFLD (n = 20) and healthy controls (n = 20) matched for age, sex, and body mass index with at least 4 living relatives and 2 generations of lineage participated in a familial aggregation study. A medical history was obtained from each subject and confirmed with first-degree family members.
RESULTS: NAFLD patients were more likely to have cirrhosis (odds ratio [OR] = 12.0), cardiac disease (OR, 3.0), hyperlipidemia (OR, 12.1), diabetes mellitus (DM) (OR, 9.1), renal stones (OR, 4.1), and arthritis (OR, 6.1). IR (P = .042) (the primary dependent variable) and DM (P = .013) were noted in their first-degree relatives. A trend for familial clustering of NAFLD or CC (P = .059) with a maternal linkage for disease expression also may exist. Cholelithiasis (P = .047), presumed NAFLD and/or CC (P = .049), and a trend toward IR (P = .07) were noted in the mothers, but not the fathers, of patients with NAFLD. An increased risk of DM (OR, 4.2; 95% confidence interval, 1.26-18.7; P = .013), IR (OR, 2.86; 95% confidence interval, 1.02-9.38; P = .042), and smoking (OR, 3.41; 95% confidence interval, 1.43-9.07; P = .003) was observed in first-degree relatives of NAFLD patients. No significant survival difference was observed between family cohorts.
CONCLUSIONS: Familial clustering and a potential maternal linkage for IR support a genetic predisposition for NAFLD. Alternatively, the presence of suppressor genes modifying the expression of IR in paternal lineage warrants further investigation.

Entities:  

Mesh:

Year:  2006        PMID: 16901766     DOI: 10.1016/j.cgh.2006.06.001

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  17 in total

Review 1.  Cryptogenic cirrhosis: what are we missing?

Authors:  Stephen Caldwell
Journal:  Curr Gastroenterol Rep       Date:  2010-02

2.  Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.

Authors:  Guglielmo M Trovato; Giuseppe Fabio Martines; Francesca M Trovato; Clara Pirri; Patrizia Pace; Adriana Garozzo; Angelo Castro; Daniela Catalano
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

3.  Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.

Authors:  Cyrielle Caussy; Meera Soni; Jeffrey Cui; Ricki Bettencourt; Nicholas Schork; Chi-Hua Chen; Mahdi Al Ikhwan; Shirin Bassirian; Sandra Cepin; Monica P Gonzalez; Michel Mendler; Yuko Kono; Irine Vodkin; Kristin Mekeel; Jeffrey Haldorson; Alan Hemming; Barbara Andrews; Joanie Salotti; Lisa Richards; David A Brenner; Claude B Sirlin; Rohit Loomba
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

4.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.

Authors:  Rohit Loomba; Maria Abraham; Aynur Unalp; Laura Wilson; Joel Lavine; Ed Doo; Nathan M Bass
Journal:  Hepatology       Date:  2012-07-26       Impact factor: 17.425

Review 5.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

Authors:  Naga Chalasani; Xiuqing Guo; Rohit Loomba; Mark O Goodarzi; Talin Haritunians; Soonil Kwon; Jinrui Cui; Kent D Taylor; Laura Wilson; Oscar W Cummings; Yii-Der Ida Chen; Jerome I Rotter
Journal:  Gastroenterology       Date:  2010-08-11       Impact factor: 22.682

7.  Association between inflammatory markers and liver fat: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Yasmin S Hamirani; Ronit Katz; Khurram Nasir; Irfan Zeb; Michael J Blaha; Roger S Blumenthal; Richard N Kronmal; Matthew J Budoff
Journal:  J Clin Exp Cardiolog       Date:  2014

Review 8.  Pathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-02       Impact factor: 46.802

9.  Heritability of nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Manuel A Celedon; Joel E Lavine; Rany Salem; Nzali Campbell; Nicholas J Schork; Masoud Shiehmorteza; Takeshi Yokoo; Alyssa Chavez; Michael S Middleton; Claude B Sirlin
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

Review 10.  Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.

Authors:  Silvia Sookoian; Carlos J Pirola; Luca Valenti; Nicholas O Davidson
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.